What kind of disease does this research concern?

This research concerns coronary artery disease, a heart condition including myocardial infarction and angina pectoris.

How is machine learning utilized in this study?

Machine learning is used to analyze the relationship between rare genetic variants and disease risk, thereby improving the accuracy of risk prediction.

What is the 'Rare Variant Score (RVS)'?

It is a new index that quantifies the risk of developing coronary artery disease based on an individual's rare genetic variants.

How will this research contribute to future medicine?

It will enable high-precision risk prediction tailored to individual genetic characteristics, contributing to the development of personalized preventive measures and treatments.

Where was this research conducted?

The research was conducted by a group from the Graduate School of Medicine, Chiba University, and the RIKEN Center for Integrative Medical Sciences.

AI News NQ Analysis

Machine Learning Unlocks 'Rare Genetic Variants' in Coronary Artery Disease - Towards Personalized Prevention with High-Precision Risk Prediction

Key facts

Machine Learning Unlocks 'Rare Genetic Variants' in Coronary Artery Disease - Towards Personalized Prevention with High-Precision Risk Prediction
A research group at Chiba University has utilized machine learning to elucidate the contribution of rare genetic variants to coronary artery disease in the Japanese population, significantly improving the accuracy of disease risk stratification. The newly developed 'Rare Variant Score (RVS)' is expected to enable more precise risk prediction when combined with the conventional Polygenic Risk Score (PRS), contributing to personalized prevention and precision medicine.
Source: PR TIMES
Date: Thu Jun 11 2026 23:00:02 GMT+0900 (Japan Standard Time)

Direct answer

A research group at Chiba University has utilized machine learning to elucidate the contribution of rare genetic variants to coronary artery disease in the Japanese population, significantly improving the accuracy of disease risk stratification. The newly developed 'Rare Variant Score (RVS)' is expected to enable more precise risk prediction when combined with the conventional Polygenic Risk Score (PRS), contributing to personalized prevention and precision medicine.

Citation: Machine Learning Unlocks 'Rare Genetic Variants' in Coronary Artery Disease - Towards Personalized Prevention with High-Precision Risk Prediction (Thu Jun 11 2026 23:00:02 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Thu Jun 11 2026 23:00:02 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

A research group at Chiba University has utilized machine learning to elucidate the contribution of rare genetic variants to coronary artery disease in the Japanese population, significantly improving the accuracy of disease risk stratification. The newly developed 'Rare Variant Score (RVS)' is expected to enable more precise risk prediction when combined with the conventional Polygenic Risk Score (PRS), contributing to personalized prevention and precision medicine.

AI Analysis

Frequently Asked Questions

Q: What kind of disease does this research concern?: A: This research concerns coronary artery disease, a heart condition including myocardial infarction and angina pectoris.
Q: How is machine learning utilized in this study?: A: Machine learning is used to analyze the relationship between rare genetic variants and disease risk, thereby improving the accuracy of risk prediction.
Q: What is the 'Rare Variant Score (RVS)'?: A: It is a new index that quantifies the risk of developing coronary artery disease based on an individual's rare genetic variants.
Q: How will this research contribute to future medicine?: A: It will enable high-precision risk prediction tailored to individual genetic characteristics, contributing to the development of personalized preventive measures and treatments.
Q: Where was this research conducted?: A: The research was conducted by a group from the Graduate School of Medicine, Chiba University, and the RIKEN Center for Integrative Medical Sciences.